TenSixty Biosciences, Inc.
Biotechnology company · Cambridge, Massachusetts, United States
TenSixty Biosciences, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2021. It has reported private securities offerings to the US SEC, most recently $7.2 million sold in a notice filed in 2022.
TenSixty Biosciences at a glance
What does TenSixty Biosciences do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $7.2 million sold (2022).
Frequently asked questions about TenSixty Biosciences
Where is TenSixty Biosciences headquartered?
TenSixty Biosciences, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does TenSixty Biosciences do?
TenSixty Biosciences, Inc. is a biotechnology company.
When was TenSixty Biosciences founded?
The earliest incorporation on record for TenSixty Biosciences, Inc. is in 2021, according to public company registers.
Similar companies
- Editas Medicine, Inc.Cambridge, Massachusetts, United States
- Moderna, Inc.Cambridge, Massachusetts, United States
- Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
- Beam Therapeutics Inc.Cambridge, Massachusetts, United States
- Genzyme CorpCambridge, Massachusetts, United States
- Neutrolis Inc.Cambridge, Massachusetts, United States
- Biogen Inc.Cambridge, Massachusetts, United States
- Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences